November news: Accelerating cell and gene therapies towards commercialisation

It is at the heart of our mission to accelerate the progression of UK cell and gene therapy companies towards commercialisation. In November, we launched our commercial readiness advice clinics programme, offering SMEs and spin-out companies access to expert, tailored support to evaluate and progress their product towards industrialisation.